Investor directoryTruffle Capital
Truffle Capital aims to drive the creation and development of companies in BioMedTech and Fintech through active governance and strategic partnerships.
What they invest in
Sectors
Geographies
EU
The facts
- Typical cheque
- €0.5M – €5M
- Headquarters
- Paris, France
- Founded
- 2001
More portfolio companies
Carbios (PAR: ALCRB)DgPaysAbivax (PAR: ABVX)CarmatHydrosatCellaïonAltimmune (NAS: ALT)Carvolix (PAR: CVX)LevenueEVEXTA BIOBridge (Paris)Cake (Media and Information Services (B2B))IPaidThatObatCaranx MedicalCachet.RollingFundsWeGroupAcerdeAcasiMONI (Financial Software)SmartpushScalensProgexia
and 10 more
Recent rounds
Wyden
$16.9MSeries BFinTechTruffle CapitalleadSBI-Sygnum-Azimut Digital Asset Opportunity FundC3 Venture CapitalPostFinance Ventures · +1 more in the source
Switzerlandsiliconcanals.com
Rounds Truffle Capital took part in, as reported by the linked articles. See who else is investing right now.
Questions founders ask
- How much does Truffle Capital typically invest?
- Truffle Capital states a typical cheque of €0.5M – €5M.
- Which stages does Truffle Capital invest in?
- Truffle Capital invests at Seed, Series A, Series B and Growth.
- Where is Truffle Capital based?
- Truffle Capital is headquartered in Paris, France.
Does Truffle Capital fit your round?
In 30 minutes you'll know which funds matter for your round.
Request accessAre you Truffle Capital? Tell us what to correct and we will update it — or ask us to remove the entry.